CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2020—Qiagen has launched the QIAseq SARS-CoV-2 Primer Panel for next-generation sequencing of the novel coronavirus genome and integrated analysis and interpretation workflows for insights into the evolution and spread of the virus.
The two-step process uses QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample and then generate libraries compatible with Illumina sequencing platforms.
Pages: 1 2